Editorial desk
Contact Wolverine Research
Corrections, source suggestions, and editorial questions about our BPC-157 TB-500 coverage.
Editorial inquiries only
Wolverine Research is an editorial terminal covering the BPC-157 TB-500 literature, and this desk handles editorial matters only: corrections, citation suggestions, and questions about how we read a study. If you believe a figure or citation on this site is wrong, tell us which page and which [N] marker, and we will check it against the source.
We do not provide medical or legal advice, we do not answer dosing questions, and we do not supply, sell, or facilitate access to either peptide or the blend. Questions about treatment belong with an appropriately licensed prescriber, not with an editorial publisher.
Send a message
Use the form below to reach the editorial desk. Include the page URL and, where relevant, the citation number so we can trace a claim to its source quickly. We read every message but cannot offer individualized health guidance, and we will not respond to requests to obtain, price, or supply the compound.
For the regulatory and access picture, the Wolverine legal status page already lays out the present-tense FDA 503A and WADA record; for the human dataset, see the BPC-157 TB-500 clinical evidence page before writing in.